Syncom Formulations (India) Limited evaluates its capital allocation strategies annually, periodically declaring dividends based on net operating profits, cash flow generation, and reinvestment requirements within its pharmaceutical manufacturing operations. Shareholders should check corporate financial announcements and official ex-dividend schedules for the exact distribution amounts declared for specific fiscal periods.